A head-to-head comparison review of biological and toxicological studies of isomaltulose, d-tagatose, and trehalose on glycemic control.


Journal

Critical reviews in food science and nutrition
ISSN: 1549-7852
Titre abrégé: Crit Rev Food Sci Nutr
Pays: United States
ID NLM: 8914818

Informations de publication

Date de publication:
2022
Historique:
pubmed: 16 3 2021
medline: 20 7 2022
entrez: 15 3 2021
Statut: ppublish

Résumé

Diabetes mellitus is the most common metabolic disorder contributing to significant morbidity and mortality in humans. Different preventive and therapeutic agents, as well as various pharmacological strategies or non-pharmacological tools, improve the glycemic profile of diabetic patients. Isomaltulose, d-tagatose, and trehalose are naturally occurring, low glycemic sugars that are not synthesized by humans but widely used in food industries. Various studies have shown that these carbohydrates can regulate glucose metabolism and provide support in maintaining glucose homeostasis in patients with diabetes, but also can improve insulin response, subsequently leading to better control of hyperglycemia. In this review, we discussed the anti-hyperglycemic effects of isomaltulose, D-tagatose, and trehalose, comparing their properties with other known sweeteners, and highlighting their importance for the development of the pharmaceutical and food industries.

Identifiants

pubmed: 33715524
doi: 10.1080/10408398.2021.1895057
doi:

Substances chimiques

Blood Glucose 0
Hexoses 0
Isomaltose 67I334IX2M
Trehalose B8WCK70T7I
tagatose T7A20Y888Y
isomaltulose V59P50X4UY

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5679-5704

Auteurs

Emilia Sokołowska (E)

Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, Poland.

Anna Sadowska (A)

Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, Poland.

Diana Sawicka (D)

Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, Poland.

Izabela Kotulska-Bąblińska (I)

Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, Poland.

Halina Car (H)

Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH